Myocardial Effects in Patients With ATTRv With Polyneuropathy Treated With Patisiran or Vutrisiran
Myocardial Effects in Patients With ATTRv With Polyneuropathy Treated With Patisiran or Vutrisiran
Active, not recruiting · NCT05873868 · Registry updated 2026-01-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Myocardial Effects in Patients With ATTRv With Polyneuropathy Treated With Patisiran or Vutrisiran | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, amyloidosis, familial amyloid neuropathy, hereditary amyloidosis, hereditary disease, inborn errors of metabolism, metabolic disease, proteostasis deficiencies | Active, not recruiting | Not stated | 2026-01-05 | NCT05873868 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Rennes University Hospital | 89 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| APHP Henri Mondor | Créteil | France | 5 |
| CHU Bordeaux Haut-Levêque | Bordeaux | France | 2 |
| CHU Grenoble Alpes | Grenoble | France | 25 |
| CHU Nancy Institut Louis Mathieu | Nancy | France | 1 |
| CHU Rangueil Toulouse | Toulouse | France | 3 |